Edap Tms (NASDAQ:EDAP) Now Covered by StockNews.com

Stock analysts at StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a research note issued on Tuesday. The brokerage set a "hold" rating on the medical equipment provider's stock.

EDAP has been the topic of a number of other reports. HC Wainwright reissued a "buy" rating and set a $19.00 target price on shares of Edap Tms in a research report on Friday, March 28th. Jefferies Financial Group reiterated a "hold" rating and issued a $2.00 price objective (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. Finally, Piper Sandler lowered their target price on Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a research note on Friday, March 28th.

Edap Tms Trading Up 3.3 %

EDAP traded up $0.07 during trading on Tuesday, hitting $2.22. 59,386 shares of the company's stock were exchanged, compared to its average volume of 96,662. The stock has a 50 day moving average price of $2.00 and a 200 day moving average price of $2.29. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.36. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The firm has a market cap of $82.37 million, a P/E ratio of -3.42 and a beta of 0.13.

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The firm had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. As a group, analysts expect that Edap Tms will post -0.6 EPS for the current fiscal year.

Hedge Funds Weigh In On Edap Tms

Several large investors have recently modified their holdings of EDAP. Illumine Investment Management LLC acquired a new stake in Edap Tms during the fourth quarter valued at approximately $50,000. Jane Street Group LLC increased its holdings in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares during the last quarter. Millennium Management LLC raised its position in shares of Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after acquiring an additional 33,558 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after purchasing an additional 25,650 shares during the period. Finally, Schonfeld Strategic Advisors LLC increased its stake in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock valued at $355,000 after purchasing an additional 52,500 shares during the last quarter. Institutional investors own 62.74% of the company's stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.